Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Vivara board member cuts stake by R$ 1.18 million in on-market sale

Vivara board member cuts stake by R$ 1.18 million in on-market sale

BitgetBitget2026/10/09 22:03

A Vivara board member sold 50,000 common shares in a spot sale on day 4 at 23.60194. Total proceeds were R$ 1.18 million; average sale price was 23.60194 per share. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivara Participações SA published the original content used to generate this news brief on October 09, 2026, and is solely responsible for the information contained therein.

  • A Vivara board member sold 50,000 common shares in a spot sale on day 4 at 23.60194.
  • Total proceeds were R$ 1.18 million; average sale price was 23.60194 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivara Participações SA published the original content used to generate this news brief on October 09, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

No scientific evidence but viral on social media: “Bodybuilding miracle drug” peptide products deregulation file sent to the White House for review, Hims&Hers (HIMS.US) surged 6% in one day.

The temporary admission policy for peptides has been submitted to the White House for review, and compounding pharmacies are expected to receive approval to produce BPC-157 and other substances; HIMS closed up 6% on Thursday.

智通财经•2026/10/16 00:11